In vitro biodistribution of silver nanoparticles in isolated perfused porcine skin flaps

Journal of Applied Toxicology

Volumn 32, Issue 11, 2012, Pages 913-919

  Leavens, Teresa L ^a   Monteiro Riviere, Nancy A ^a   Inman, Alfred O ^a   Brooks, James D ^a   Oldenburg, Steven J ^b   Riviere, Jim E ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b NanoComposix Inc   (United States)

Author keywords

Biodistribution; Silver nanoparticles; Skin

Indexed keywords

CITRIC ACID; SILICON DIOXIDE; SILVER NANOPARTICLE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); DIFFUSION; FEMALE; FLOW RATE; IN VIVO STUDY; ISOLATED PERFUSED PORCINE SKIN FLAP; MASS SPECTROMETRY; NONHUMAN; PERFUSION; PRIORITY JOURNAL; SKIN FLAP;

ANIMALS; METAL NANOPARTICLES; NANOPARTICLES; PERFUSION; SILVER; SKIN; SWINE; TISSUE DISTRIBUTION;

SUS;

EID: 84866866954     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2750     Document Type: Article

References (33)

1. Bernstein EM. 1987. Humane Innovations and Alternatives in Animal Experimentation: A Notebook. Psychologists for the Ethical Treatment of Animals: Saranac Lake, NY; 7.
2. Bowden LP, Royer MC, Hallman JR, Lewin-Smith M, Lupton GP. 2011. Rapid onset of argyria induced by a X-containing dietary supplement. J. Cutan. Pathol. 38: 832-835.
3. Bowman KF, Monteiro-Riviere NA, Riviere JE, 1991. Development of surgical techniques for preparation of in vitro isolated perfused porcine skin flaps for percutaneous absorption studies. Am. J. Vet. Res. 52: 75-82.
4. Chen X, Schluesener HJ. 2008. Nanosilver: a nanoproduct in medical application. Toxicol. Lett. 176: 1-12.
5. Croteau MN, Misra SK, Luoma SN, Valsami-Jones E. 2011. Silver bioaccumulation dynamics in a freshwater invertebrate after aqueous and dietary exposures to nanosized and ionic Ag. Environ. Sci. Technol. 45: 6600-6607.
6. Drake PL, Hazelwood KJ. 2005. Exposure-related health effects of silver and silver compounds: A review. Ann. Occup. Hyg. 49: 575-585.
7. Farkas J, Christian P, Gallego-Urrea JA, Roos N, Hassellov M, Tollefsen KE, Thomas KV. 2011. Uptake and effects of manufactured X nanoparticles in rainbow trout (oncorhynchus mykiss) gill cells RID F-3693-2010. Aquat. Toxicol. 101: 117-125.
8. Garza-Ocanas L, Ferrer DA, Burt J, Diaz-Torres LA, Cabrera MR, Rodriguez VT, Rangel RL, Romanovicz D, Jose-Yacaman M. 2010. Biodistribution and long-term fate of X nanoparticles functionalized with bovine serum albumin in rats. Metallomics 2: 204-210.
9. Gaul LE, Staud AH. 1935.Clinical spectroscopy. Seventy cases of generalized argyrosis following organic and colloidal Ag medication. JAMA 104: 1387-1390.
10. Gottschalk F, Nowack B. 2011. The release of engineered nanomaterials to the environment. J. Environ. Monit. 13: 1145-1155.
11. Hagens WI, Oomen AG, de Jong WH, Cassee FR, Sips AJ. 2007. What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul. Toxicol. Pharmacol. 49: 217-229.
12. International Programme on Chemical Safety. 2010. In Characterization and Application of Physiologically Based Pharmacokinetic Models in Risk Assessment, Sheffer M (ed.). World Health Organization: Geneva; 91 (Harmonization project document; no. 9).
13. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. 2010. A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity. Crit. Rev. Toxicol. 40: 328-346.
14. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu IJ. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of X nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 20: 575-583.
15. Kim Y, Song M, Park J, Song K, Ryu H, Chung Y, Chang H, Lee J, Oh K, Kelman BJ, Hwang IK, Yu IJ. 2010. Subchronic oral toxicity of silver nanoparticles. Part. Fibre Toxicol. 7: 20; doi: 10.1186/1743-8977-7-20.
16. Kim Y, Suh HS, Cha HJ, Kim SH, Jeong KS, Kim DH. 2009. A case of generalized argyria after ingestion of colloidal silver solution. Am. J. Ind. Med. 52: 246-250.
17. Kittler S, Greulich C, Diendorf J, Köller M, Epple M. 2010. Toxicity of Ag nanoparticles increases during storage because of slow dissolution under release if Ag ions. Chem. Mater. 22: 4548-4554.
18. Lankveld DPK, Oomen AG, Krystek P, Neigh A, Troost-de Jong A, Noorlander CW, Van Eijkeren JCH, Geertsma RE, De Jong WH. 2010. The kinetics of the tissue distribution of Agnanoparticles of different sizes. Biomaterials 31: 8350-8361.
19. Leavens T, Xia X, Lee H, Monteiro-Riviere N, Brooks J, Riviere J. 2010. Evaluation of perfused porcine skin as a model system to quantitate tissue distribution of fullerene nanoparticles. Toxicol. Lett. 197: 1-6.
20. Lee HA, Imran M, Monteiro-Riviere NA, Colvin VL, Yu WW, Riviere JE. 2007. Biodistribution of quantum dot nanoparticles in perfused skin: evidence of coating dependency and periodicity in arterial extraction. Nano Lett. 7: 2865-2870.
21. Lee HA, Leavens TL, Mason SE, Monteiro-Riviere NA, Riviere JE. 2009. Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model. Nano Lett. 9: 794-799.
22. Lin P, Chen J, Chang LW, Wu J, Redding L, Chang H, Yeh T, Yang C, Tsai M, Wang H, Kuo Y, Yang R. 2008. Computational and ultrastructural toxicology of a nanoparticle, quantum dot 705, in mice. Environ. Sci. Technol. 42: 6264-6270.
23. Park EJ, Bae E, Yi J, Kim Y, Choi K, Lee SH, Yoon J, Lee BC, Park K. 2010. Repeated-dose toxicity and inflammatory responses in mice by oral administration of Ag nanoparticles. Environ. Toxicol. Pharmacol. 30: 162-168.
24. Riviere JE. 2009. Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots. Wires Nanomed Nanobiotechnol. 1: 26-34.
25. Riviere JE, Bowman KF, Monteiro-Riviere NA, Dix LP, Carver MP. 1986. The isolated perfused porcine skin flap (IPPSF). I. A novel in vitro model for percutaneous absorption and cutaneous toxicology studies. Fundam. Appl. Toxicol. 7: 444-453.
26. Riviere JE, Monteiro-Riviere NA. 1991. The isolated perfused porcine skin flap as an in vitro model for percutaneous absorption and cutaneous toxicology. CRC Cr. Rev. Toxicol. 21: 329-344.
27. Samberg ME, Oldenburg SJ, Monteiro-Riviere NA. 2010. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ. Health Perspect. 118: 407-413.
28. Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. 2006. Ag-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J. Trauma 60: 648-652.
29. US Environmental Protection Agency. 1991. Integrated Risk Information System. Ag (CASRN 7440-22-4) [WWW document]. URL http://www.epa.gov/iris/subst/0099.htm#reforal [accessed on 20 September 2011].
30. US Food and Drug Administration. 2009. Consumer Advisory: Dietary Supplements Containing Ag May Cause Permanent Discoloration of the Skin and Mucous Membranes (Argyria). Department of Health and Human Services: College Park, MD. http://www.fda.gov/Food/DietarySupplements/Alerts/ucm184087.htm. [accessed on 20 September 2011].
31. Vlachou E, Chipp E, Shale E, Wilson YT, Papini R, Moiemen NS. 2007. The safety of nanocrystalline silver dressings on burns: A study of systemic silver absorption. Burns 33: 979-985.
32. Williams LR, Leggett RW. 1989. Reference values for resting blood flow to organs of man. Clin. Phys. Meas. 10: 187-217.
33. Woodrow Wilson International Center for Scholars. 2011. A nanotechnology consumer products inventory [WWW document]. URL http://www.nanotechproject.org/inventories/consumer/analysis_draft/ [accessed on 14 December 2011].